Decrease in Adiponectin Levels Correlates to Growth Response in Growth Hormone-Treated Children

Background/Aims: Adiponectin is secreted by adipose tissue and circulates in human plasma at high levels. Decreased adiponectin levels are associated with insulin resistance and obesity. The aim of this study was to investigate whether changes in serum adiponectin levels are related to the growth re...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:HORMONE RESEARCH IN PAEDIATRICS 2009-01, Vol.71 (4), p.213-218
Hauptverfasser: Andersson, B., Carlsson, L.M.S., Carlsson, B., Albertsson-Wikland, K., Bjarnason, R.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 218
container_issue 4
container_start_page 213
container_title HORMONE RESEARCH IN PAEDIATRICS
container_volume 71
creator Andersson, B.
Carlsson, L.M.S.
Carlsson, B.
Albertsson-Wikland, K.
Bjarnason, R.
description Background/Aims: Adiponectin is secreted by adipose tissue and circulates in human plasma at high levels. Decreased adiponectin levels are associated with insulin resistance and obesity. The aim of this study was to investigate whether changes in serum adiponectin levels are related to the growth response, insulin levels and insulin resistance during growth hormone (GH) treatment. Methods: The study included 94 short prepubertal children (19 girls and 75 boys). The mean age at the start of daily GH injections was 9.04 ± 2.38 years. Adiponectin levels in serum were measured using an ELISA. Results: At baseline, adiponectin correlated with the first-year growth response (r = 0.26, p = 0.012). Adiponectin decreased significantly after 1 week, 3 months and 1 year from 14.5 ± 5.71 to 13.1 ± 5.22 (p < 0.0001), 10.3 ± 4.82 (p < 0.0001) and 12.5 ± 5.34 μg/ml (p < 0.0001), respectively. There were significant correlations between the first-year growth response and the decrease in adiponectin levels after 3 months and 1 year (r = –0.38, p < 0.0001 and r = –0.47, p < 0.0001, respectively). No correlations between adiponectin, insulin and the homeostasis model assessment of insulin resistance were seen. Conclusions: GH treatment in prepubertal children decreases serum adiponectin levels, and the decrease is correlated to the growth response. No correlations between adiponectin and insulin levels or insulin resistance were found.
doi_str_mv 10.1159/000201110
format Article
fullrecord <record><control><sourceid>proquest_swepu</sourceid><recordid>TN_cdi_proquest_miscellaneous_67105032</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2770088371</sourcerecordid><originalsourceid>FETCH-LOGICAL-c412t-30173101fa1e5370ac6c429b34ca2f590a884a7106992f1da93f3772eccb5e023</originalsourceid><addsrcrecordid>eNqN0uFr1TAQAPAgihvbPvhdpCAIA6u5pGmaj4-3uQ0eCDL9GvLS61u3tqlJ49h_vzxaniAofspx_O5CLkfIG6CfAIT6TCllFADoC3IMZclzVrHy5SGG6oichXCfGOWVVCBfkyNQTFQS-DHRF2g9moBZO2Sruh3dgHZK8QZ_YReytfMeOzNhyCaXXXn3ON1l3zAkN9csqWvn-1Sa36ZmE9bZ-q7tao_DKXnVmC7g2XKekO9fLm_X1_nm69XNerXJbQFsyjkFyYFCYwAFl9TY0hZMbXlhDWuEoqaqCiOBlkqxBmqjeMOlZGjtViBl_ITkc9_wiGPc6tG3vfFP2plWL6mHFKEWQvFC_NPv4qhTahf3HgSUUib_8a_-ov2x0s7vdIwaGCto9Z-8j5qL9HuJf5j56N3PiGHSfRssdp0Z0MWgy_RyQfn-me__gPcu-iFNVu9nkyZXCEjqfFbWuxA8Nof7ger90ujD0iT7bukYtz3Wv-WyIgm8ncGD8Tv0B7DUPwOuQcRg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1069370451</pqid></control><display><type>article</type><title>Decrease in Adiponectin Levels Correlates to Growth Response in Growth Hormone-Treated Children</title><source>Karger Journals</source><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Andersson, B. ; Carlsson, L.M.S. ; Carlsson, B. ; Albertsson-Wikland, K. ; Bjarnason, R.</creator><creatorcontrib>Andersson, B. ; Carlsson, L.M.S. ; Carlsson, B. ; Albertsson-Wikland, K. ; Bjarnason, R. ; Swedish Study Group for Growth Hormone Treatment</creatorcontrib><description>Background/Aims: Adiponectin is secreted by adipose tissue and circulates in human plasma at high levels. Decreased adiponectin levels are associated with insulin resistance and obesity. The aim of this study was to investigate whether changes in serum adiponectin levels are related to the growth response, insulin levels and insulin resistance during growth hormone (GH) treatment. Methods: The study included 94 short prepubertal children (19 girls and 75 boys). The mean age at the start of daily GH injections was 9.04 ± 2.38 years. Adiponectin levels in serum were measured using an ELISA. Results: At baseline, adiponectin correlated with the first-year growth response (r = 0.26, p = 0.012). Adiponectin decreased significantly after 1 week, 3 months and 1 year from 14.5 ± 5.71 to 13.1 ± 5.22 (p &lt; 0.0001), 10.3 ± 4.82 (p &lt; 0.0001) and 12.5 ± 5.34 μg/ml (p &lt; 0.0001), respectively. There were significant correlations between the first-year growth response and the decrease in adiponectin levels after 3 months and 1 year (r = –0.38, p &lt; 0.0001 and r = –0.47, p &lt; 0.0001, respectively). No correlations between adiponectin, insulin and the homeostasis model assessment of insulin resistance were seen. Conclusions: GH treatment in prepubertal children decreases serum adiponectin levels, and the decrease is correlated to the growth response. No correlations between adiponectin and insulin levels or insulin resistance were found.</description><identifier>ISSN: 1663-2818</identifier><identifier>ISSN: 0301-0163</identifier><identifier>ISSN: 1423-0046</identifier><identifier>EISSN: 1663-2826</identifier><identifier>EISSN: 1423-0046</identifier><identifier>DOI: 10.1159/000201110</identifier><identifier>PMID: 19258713</identifier><language>eng</language><publisher>Basel, Switzerland: S. Karger AG</publisher><subject>Adiponectin ; Adiponectin - blood ; Adolescent ; blood ; Child ; Child Development ; Child, Preschool ; Children ; Female ; Growth hormone ; Growth response ; Human Growth Hormone ; Human Growth Hormone - therapeutic use ; Humans ; Insulin ; Insulin Resistance ; Insulin-like growth factor-I ; Male ; Original Paper ; Pediatrics ; Pediatrik ; Preschool ; therapeutic use</subject><ispartof>HORMONE RESEARCH IN PAEDIATRICS, 2009-01, Vol.71 (4), p.213-218</ispartof><rights>2009 S. Karger AG, Basel</rights><rights>2009 S. Karger AG, Basel.</rights><rights>Copyright (c) 2009 S. Karger AG, Basel</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c412t-30173101fa1e5370ac6c429b34ca2f590a884a7106992f1da93f3772eccb5e023</citedby><cites>FETCH-LOGICAL-c412t-30173101fa1e5370ac6c429b34ca2f590a884a7106992f1da93f3772eccb5e023</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,2423,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19258713$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-35020$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-122408$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttps://gup.ub.gu.se/publication/151677$$DView record from Swedish Publication Index$$Hfree_for_read</backlink><backlink>$$Uhttp://kipublications.ki.se/Default.aspx?queryparsed=id:118394013$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Andersson, B.</creatorcontrib><creatorcontrib>Carlsson, L.M.S.</creatorcontrib><creatorcontrib>Carlsson, B.</creatorcontrib><creatorcontrib>Albertsson-Wikland, K.</creatorcontrib><creatorcontrib>Bjarnason, R.</creatorcontrib><creatorcontrib>Swedish Study Group for Growth Hormone Treatment</creatorcontrib><title>Decrease in Adiponectin Levels Correlates to Growth Response in Growth Hormone-Treated Children</title><title>HORMONE RESEARCH IN PAEDIATRICS</title><addtitle>Horm Res Paediatr</addtitle><description>Background/Aims: Adiponectin is secreted by adipose tissue and circulates in human plasma at high levels. Decreased adiponectin levels are associated with insulin resistance and obesity. The aim of this study was to investigate whether changes in serum adiponectin levels are related to the growth response, insulin levels and insulin resistance during growth hormone (GH) treatment. Methods: The study included 94 short prepubertal children (19 girls and 75 boys). The mean age at the start of daily GH injections was 9.04 ± 2.38 years. Adiponectin levels in serum were measured using an ELISA. Results: At baseline, adiponectin correlated with the first-year growth response (r = 0.26, p = 0.012). Adiponectin decreased significantly after 1 week, 3 months and 1 year from 14.5 ± 5.71 to 13.1 ± 5.22 (p &lt; 0.0001), 10.3 ± 4.82 (p &lt; 0.0001) and 12.5 ± 5.34 μg/ml (p &lt; 0.0001), respectively. There were significant correlations between the first-year growth response and the decrease in adiponectin levels after 3 months and 1 year (r = –0.38, p &lt; 0.0001 and r = –0.47, p &lt; 0.0001, respectively). No correlations between adiponectin, insulin and the homeostasis model assessment of insulin resistance were seen. Conclusions: GH treatment in prepubertal children decreases serum adiponectin levels, and the decrease is correlated to the growth response. No correlations between adiponectin and insulin levels or insulin resistance were found.</description><subject>Adiponectin</subject><subject>Adiponectin - blood</subject><subject>Adolescent</subject><subject>blood</subject><subject>Child</subject><subject>Child Development</subject><subject>Child, Preschool</subject><subject>Children</subject><subject>Female</subject><subject>Growth hormone</subject><subject>Growth response</subject><subject>Human Growth Hormone</subject><subject>Human Growth Hormone - therapeutic use</subject><subject>Humans</subject><subject>Insulin</subject><subject>Insulin Resistance</subject><subject>Insulin-like growth factor-I</subject><subject>Male</subject><subject>Original Paper</subject><subject>Pediatrics</subject><subject>Pediatrik</subject><subject>Preschool</subject><subject>therapeutic use</subject><issn>1663-2818</issn><issn>0301-0163</issn><issn>1423-0046</issn><issn>1663-2826</issn><issn>1423-0046</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqN0uFr1TAQAPAgihvbPvhdpCAIA6u5pGmaj4-3uQ0eCDL9GvLS61u3tqlJ49h_vzxaniAofspx_O5CLkfIG6CfAIT6TCllFADoC3IMZclzVrHy5SGG6oichXCfGOWVVCBfkyNQTFQS-DHRF2g9moBZO2Sruh3dgHZK8QZ_YReytfMeOzNhyCaXXXn3ON1l3zAkN9csqWvn-1Sa36ZmE9bZ-q7tao_DKXnVmC7g2XKekO9fLm_X1_nm69XNerXJbQFsyjkFyYFCYwAFl9TY0hZMbXlhDWuEoqaqCiOBlkqxBmqjeMOlZGjtViBl_ITkc9_wiGPc6tG3vfFP2plWL6mHFKEWQvFC_NPv4qhTahf3HgSUUib_8a_-ov2x0s7vdIwaGCto9Z-8j5qL9HuJf5j56N3PiGHSfRssdp0Z0MWgy_RyQfn-me__gPcu-iFNVu9nkyZXCEjqfFbWuxA8Nof7ger90ujD0iT7bukYtz3Wv-WyIgm8ncGD8Tv0B7DUPwOuQcRg</recordid><startdate>20090101</startdate><enddate>20090101</enddate><creator>Andersson, B.</creator><creator>Carlsson, L.M.S.</creator><creator>Carlsson, B.</creator><creator>Albertsson-Wikland, K.</creator><creator>Bjarnason, R.</creator><general>S. Karger AG</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7U7</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>RC3</scope><scope>7X8</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D93</scope><scope>DF2</scope><scope>F1U</scope></search><sort><creationdate>20090101</creationdate><title>Decrease in Adiponectin Levels Correlates to Growth Response in Growth Hormone-Treated Children</title><author>Andersson, B. ; Carlsson, L.M.S. ; Carlsson, B. ; Albertsson-Wikland, K. ; Bjarnason, R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c412t-30173101fa1e5370ac6c429b34ca2f590a884a7106992f1da93f3772eccb5e023</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adiponectin</topic><topic>Adiponectin - blood</topic><topic>Adolescent</topic><topic>blood</topic><topic>Child</topic><topic>Child Development</topic><topic>Child, Preschool</topic><topic>Children</topic><topic>Female</topic><topic>Growth hormone</topic><topic>Growth response</topic><topic>Human Growth Hormone</topic><topic>Human Growth Hormone - therapeutic use</topic><topic>Humans</topic><topic>Insulin</topic><topic>Insulin Resistance</topic><topic>Insulin-like growth factor-I</topic><topic>Male</topic><topic>Original Paper</topic><topic>Pediatrics</topic><topic>Pediatrik</topic><topic>Preschool</topic><topic>therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Andersson, B.</creatorcontrib><creatorcontrib>Carlsson, L.M.S.</creatorcontrib><creatorcontrib>Carlsson, B.</creatorcontrib><creatorcontrib>Albertsson-Wikland, K.</creatorcontrib><creatorcontrib>Bjarnason, R.</creatorcontrib><creatorcontrib>Swedish Study Group for Growth Hormone Treatment</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Toxicology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Umeå universitet</collection><collection>SWEPUB Uppsala universitet</collection><collection>SWEPUB Göteborgs universitet</collection><jtitle>HORMONE RESEARCH IN PAEDIATRICS</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Andersson, B.</au><au>Carlsson, L.M.S.</au><au>Carlsson, B.</au><au>Albertsson-Wikland, K.</au><au>Bjarnason, R.</au><aucorp>Swedish Study Group for Growth Hormone Treatment</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Decrease in Adiponectin Levels Correlates to Growth Response in Growth Hormone-Treated Children</atitle><jtitle>HORMONE RESEARCH IN PAEDIATRICS</jtitle><addtitle>Horm Res Paediatr</addtitle><date>2009-01-01</date><risdate>2009</risdate><volume>71</volume><issue>4</issue><spage>213</spage><epage>218</epage><pages>213-218</pages><issn>1663-2818</issn><issn>0301-0163</issn><issn>1423-0046</issn><eissn>1663-2826</eissn><eissn>1423-0046</eissn><abstract>Background/Aims: Adiponectin is secreted by adipose tissue and circulates in human plasma at high levels. Decreased adiponectin levels are associated with insulin resistance and obesity. The aim of this study was to investigate whether changes in serum adiponectin levels are related to the growth response, insulin levels and insulin resistance during growth hormone (GH) treatment. Methods: The study included 94 short prepubertal children (19 girls and 75 boys). The mean age at the start of daily GH injections was 9.04 ± 2.38 years. Adiponectin levels in serum were measured using an ELISA. Results: At baseline, adiponectin correlated with the first-year growth response (r = 0.26, p = 0.012). Adiponectin decreased significantly after 1 week, 3 months and 1 year from 14.5 ± 5.71 to 13.1 ± 5.22 (p &lt; 0.0001), 10.3 ± 4.82 (p &lt; 0.0001) and 12.5 ± 5.34 μg/ml (p &lt; 0.0001), respectively. There were significant correlations between the first-year growth response and the decrease in adiponectin levels after 3 months and 1 year (r = –0.38, p &lt; 0.0001 and r = –0.47, p &lt; 0.0001, respectively). No correlations between adiponectin, insulin and the homeostasis model assessment of insulin resistance were seen. Conclusions: GH treatment in prepubertal children decreases serum adiponectin levels, and the decrease is correlated to the growth response. No correlations between adiponectin and insulin levels or insulin resistance were found.</abstract><cop>Basel, Switzerland</cop><pub>S. Karger AG</pub><pmid>19258713</pmid><doi>10.1159/000201110</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1663-2818
ispartof HORMONE RESEARCH IN PAEDIATRICS, 2009-01, Vol.71 (4), p.213-218
issn 1663-2818
0301-0163
1423-0046
1663-2826
1423-0046
language eng
recordid cdi_proquest_miscellaneous_67105032
source Karger Journals; MEDLINE; Alma/SFX Local Collection
subjects Adiponectin
Adiponectin - blood
Adolescent
blood
Child
Child Development
Child, Preschool
Children
Female
Growth hormone
Growth response
Human Growth Hormone
Human Growth Hormone - therapeutic use
Humans
Insulin
Insulin Resistance
Insulin-like growth factor-I
Male
Original Paper
Pediatrics
Pediatrik
Preschool
therapeutic use
title Decrease in Adiponectin Levels Correlates to Growth Response in Growth Hormone-Treated Children
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T00%3A52%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_swepu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Decrease%20in%20Adiponectin%20Levels%20Correlates%20to%20Growth%20Response%20in%20Growth%20Hormone-Treated%20Children&rft.jtitle=HORMONE%20RESEARCH%20IN%20PAEDIATRICS&rft.au=Andersson,%20B.&rft.aucorp=Swedish%20Study%20Group%20for%20Growth%20Hormone%20Treatment&rft.date=2009-01-01&rft.volume=71&rft.issue=4&rft.spage=213&rft.epage=218&rft.pages=213-218&rft.issn=1663-2818&rft.eissn=1663-2826&rft_id=info:doi/10.1159/000201110&rft_dat=%3Cproquest_swepu%3E2770088371%3C/proquest_swepu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1069370451&rft_id=info:pmid/19258713&rfr_iscdi=true